|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
WHO004913035 |
| 003 |
DE-627 |
| 005 |
20230425171038.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
210507s2021 xx |||||o 00| ||eng c |
| 035 |
|
|
|a (DE-627)WHO004913035
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)EUCTR2015-004725-13-DE
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)SHP620-303
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)NCT02931539
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a A study to determine how safe and effective maribavir versus standard of care is in treating cytomegalovirus in transplant patients
|b A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients with Cytomegalovirus (CMV) Infections that are Refractory or Resistant to Treatment with Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir.
|
| 264 |
|
1 |
|c 2021
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 21-12-2016, Last updated: 2022-11-24
|
| 650 |
|
4 |
|a Medical Condition: CMV infections resistant or refractory in transplant patients MedDRA version: 20.0Level: LLTClassification code 10021819Term: Infection in marrow transplant recipientsSystem Organ Class: 100000004862 MedDRA version: 20.0Level: LLTClassification code 10021829Term: Infection in solid organ transplant recipientsSystem Organ Class: 100000004862;Therapeutic area: Diseases [C] - Virus Diseases [C02]
|
| 650 |
|
4 |
|a Study Type: Interventional
|
| 650 |
|
4 |
|a Phase: Phase 3
|
| 650 |
|
4 |
|a Recruitment Status: Not yet recruiting
|
| 650 |
|
4 |
|a 610
|
| 773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2021) vom: 14. Juni
|
| 773 |
1 |
8 |
|g year:2021
|g day:14
|g month:06
|
| 856 |
4 |
0 |
|u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004725-13
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_CTG
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2021
|b 14
|c 06
|
Klinische Studie